AIG Focused Dividend Strategy B (FDSBX)
14.10
+0.12 +0.86%
May 29
USD
Key Stats
| Expense Ratio | 1.70% |
| Total Assets Under Management | 5.668B |
| Share Class Assets Under Management | 209.60M |
| Net Asset Value | 14.10 |
| Turnover Ratio | 37.00% |
| 1 Year Fund Level Flows | -3.959B |
Performance & Returns
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | 0.00% | 1.36% | 90 |
| 3M | -3.85% | -4.01% | 51 |
| 6M | -14.77% | -13.27% | 66 |
| YTD | -17.27% | -15.55% | 70 |
| 1Y | -5.67% | -3.09% | 73 |
| 3Y | -0.26% | 2.43% | 85 |
| 5Y | 2.32% | 3.90% | 79 |
| 10Y | 9.58% | 9.07% | 38 |
| 15Y | 7.43% | 6.00% | 13 |
| 20Y | 7.07% | 6.05% | 22 |
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.79% | 0.79% | 0.00% |
| Stock | 99.21% | 99.21% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00% |
| Greater Europe | 0.00% |
| United Kingdom | 0.00% |
| Europe Developed | 0.00% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.00% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.00% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
Stock Sector Exposure
| Basic Materials | 5.13% |
| Communication Services | 9.84% |
| Consumer Cyclical | 8.06% |
| Consumer Defensive | 14.62% |
| Energy | 5.33% |
| Financial Services | 3.52% |
| Healthcare | 25.31% |
| Industrials | 11.21% |
| Real Estate | 0.00% |
| Technology | 16.98% |
| Utilities | 0.00% |
Stock Market Capitalization
| Giant | 37.04% |
| Large | 41.73% |
| Medium | 19.12% |
| Small | 2.11% |
| Micro | 0.00% |
Stock Style Exposure
| Large Cap Value | 65.22% |
| Large Cap Blend | 13.55% |
| Large Cap Growth | 0.00% |
| Mid Cap Value | 19.12% |
| Mid Cap Blend | 0.00% |
| Mid Cap Growth | 0.00% |
| Small Cap Value | 2.11% |
| Small Cap Blend | 0.00% |
| Small Cap Growth | 0.00% |
View More Holdings
As of March 31, 2020
Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | 3.89% | 75.34 | -3.20% |
| CAT | Caterpillar Inc | 3.89% | 120.70 | +0.47% |
| MO | Altria Group Inc | 3.87% | 39.20 | +0.38% |
| CAH | Cardinal Health Inc | 3.86% | 54.73 | +0.07% |
| HPQ | HP Inc | 3.81% | 15.16 | +0.13% |
| BMY | Bristol-Myers Squibb Company | 3.80% | 60.23 | +0.85% |
| ABBV | AbbVie Inc | 3.69% | 90.89 | -1.92% |
| MMM | 3M Co | 3.67% | 155.71 | -0.47% |
| PM | Philip Morris International Inc | 3.63% | 73.72 | +0.49% |
| KHC | The Kraft Heinz Co | 3.61% | 30.44 | -0.10% |
Advertisement
Basic Info
| Investment Strategy | |
|---|---|
| The investment seeks total return (including capital appreciation and current income). The fund's principal investment strategy is value. The value oriented philosophy to which the fund subscribes is that of investing in securities believed to be undervalued in the market. The selection criteria is usually calculated to identify stocks of companies with solid financial strength that have attractive valuations and that may have generally been overlooked by the market. At least 80% of the fund's net assets, plus any borrowings for investment purposes, will be invested in dividend yielding equity securities. | |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FDSAX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | AIG |
| Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Reports | |
| One Page Report | Download |
Manager Info
| Name | Tenure |
|---|---|
| Andrew Sheridan | 6.54 yrs |
| Jane Bayar Algieri | 0.33 yrs |
| Timothy Campion | 6.54 yrs |
| Timothy Pettee | 6.54 yrs |
Net Fund Flows
| 1M | -245.57M |
| 3M | -1.109B |
| 6M | -2.090B |
| YTD | -1.838B |
| 1Y | -3.959B |
| 3Y | -7.939B |
| 5Y | -4.960B |
| 10Y | 1.475B |
Risk Info
| Beta (5Y) | 1.006 |
| Historical Sharpe Ratio (10Y) | 0.6687 |
| Historical Sortino (All) | 0.4074 |
| Daily Value at Risk (VaR) 1% (All) | 3.33% |
| Monthly Value at Risk (VaR) 1% (All) | 15.00% |
Fundamentals
| Dividend Yield TTM (5-29-20) | 3.26% |
| 30-Day SEC Yield (4-30-20) | 3.20% |
| 7-Day SEC Yield | -- |
| Weighted Average PE Ratio | 11.52 |
| Weighted Average Price to Sales Ratio | 0.6807 |
| Weighted Average Price to Book Ratio | 2.092 |
| Weighted Median ROE | 25.94% |
| Weighted Median ROA | 6.24% |
| Forecasted Dividend Yield | 5.67% |
| Forecasted PE Ratio | 10.06 |
| Forecasted Price to Sales Ratio | 0.6512 |
| Forecasted Price to Book Ratio | 2.174 |
| Number of Holdings | 32 |
Growth Estimates
| Forecasted 5 Yr Earnings Growth | 6.68% |
| Forecasted Book Value Growth | -5.04% |
| Forecasted Cash Flow Growth | 3.01% |
| Forecasted Earnings Growth | 2.48% |
| Forecasted Revenue Growth | 5.73% |
Comparables
Edit| FVUSA001QR | 1290 VT Equity Income IB |
| FVUSA04B5Q | EQ/Invesco Comstock IB |
| EPLBX | MainStay Epoch US Equity Yield B |
| FVUSA0024P | EQ/JPMorgan Value Opportunities IB |
| FGIBX | First Investors Growth & Income B |
Attributes
| Purchase Details | |
|---|---|
| Open to New Investors | Yes |
| Open to Existing Investors | Yes |
| Minimum Initial Investment | 500.00 USD |
| Minimum Subsequent Investment | 100.00 USD |
| Fees | |
| Actual 12B-1 Fee | 1.00% |
| Actual Management Fee | 0.44% |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | 4.00% |
| Maximum Redemption Fee | -- |
| Key Dates | |
| Inception Date | 6/8/1998 |
| Termination Date | |
| Last Annual Report Date | 10/31/2019 |
| Last Prospectus Date | 2/28/2020 |
| Attributes | |
| Exchange Traded Share | No |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
Advertisement
